Harte-Hanks (NYSE: HHS) reported Q3 EPS of $0.08, $0.02 better than the analyst estimate of $0.06. Revenue for the quarter came in at $122 million versus the consensus estimate of $119.35 million.

For earnings history and earnings-related data on Harte-Hanks (HHS) click here.